Benutzer: Gast  Login
Titel:

IMvigor010: Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) in high-risk muscle-invasive urothelial carcinoma (MIUC).

Dokumenttyp:
Meeting Abstract
Autor(en):
Hussain, Maha H. A.; Powles, Thomas; Albers, Peter; Castellano, Daniel; Daneshmand, Siamak; Gschwend, Juergen; Nishiyama, Hiroyuki; Oudard, Stephane; Tayama, Darren; Davarpanah, Nicole N.; Degaonkar, Viraj; Shi, Yi; Mariathasan, Sanjeev; Grivas, Petros; Peter, H. O.; Rosenberg, Jonathan E.; Geynisman, Daniel M.; Hoffman-Censits, Jean H.; Peter Petrylak, Daniel; Bellmunt, Joaquim
Zeitschriftentitel:
J Clin Oncol
Jahr:
2020
Band / Volume:
38 Suppl S
Heft / Issue:
15
Print-ISSN:
0732-183X
TUM Einrichtung:
Urologische Klinik und Poliklinik
 BibTeX